The latest version of ProFound AI for DBT, version 3.0, was recently cleared by the FDA in March 2021. Compared to previous versions of the software, the ProFound AI 3.0 algorithm offers up to an additional 10 percent improvement in specificity performance and up to an additional 1 percent improvement in sensitivity over its previous deep-learning AI software generation (ProFound AI Version 2.1).[2] ProFound AI version 3.0 also offers up to 40 percent faster processing on the new PowerLook platform.2 ProFound AI version 3.0 was developed using over five million images from 30,000 cases, including almost 8,000 biopsy-proven cancers, and validated on approximately one million images from 3,500 cases that included 1,200 biopsy-proven cancers.
iCAD's Breast Health Solutions suite also includes software to evaluate breast density, ProFound AI for 2D Mammography, and ProFound AI Risk, the world's first and only clinical decision support tool that provides an accurate two-year breast cancer risk estimation that is truly personalized for each woman, based only on a screening mammogram.[3]
Ad Statistics
Times Displayed: 22277
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions.
Back to HCB News
